Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    New Frontiers and Challenges for Alzheimer's Drugs

    New Frontiers and Challenges for Alzheimer's Drugs

    FromFocus on Neurology and Psychiatry

    Start listeningView podcast show

    New Frontiers and Challenges for Alzheimer's Drugs

    FromFocus on Neurology and Psychiatry

    ratings:
    Released:
    May 19, 2010
    Format:
    Podcast episode

    Description

    Guest: William Thies, PhD

    Host: Bruce Japsen


    Some 5 million Americans have Alzheimer's disease, with more cases sure to develop as the baby boomer generation ages. New potential discoveries are on the horizon. But, as Dr. William Thies, chief medical and scientific officer for the national office of the Alzheimer's Association, tells host Bruce Japsen, significant challenges and obstacles also lie ahead for these potential ground-breaking discoveries.
    Released:
    May 19, 2010
    Format:
    Podcast episode

    Titles in the series (100)

    New research and clinical trials yield frequent developments in neuroscience and mental health. ReachMD welcomes an array of leading thinkers who lend their focused expertise to these principles, central to human function and ability.